Haiting Dai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Haiting Dai has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Hanyu Wu
State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing, China
1 shared publication Lixin Xie
College of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, Beijing, P. R. China
1 shared publication- Ming Shen
Translational Medicine Laboratory, Chinese PLA General Hospital, Beijing, P. R. China
1 shared publication - Runming Wang
State Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, P. R. China
1 shared publication - Suhong Zhang
State Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, P. R. China
1 shared publication - Wenya Li
Department of Thoracic Surgery, First Hospital of China Medical University, Shenyang, Liaoning, China
1 shared publication
Latest Publications
- Open Access
- 16 November 2021
- Published by Springer Nature in Cell Death & Disease
- Vol. 12 (12) , 1-11
TMEM116 is required for lung cancer cell motility and metastasis through PDK1 signaling pathway
Transmembrane protein (TMEM) is a family of protein that spans cytoplasmic membranes and allows cell–cell and cell–environment communication. Dysregulation of TMEMs has been observed in multiple cancers. However, little is known about TMEM116 in cancer development. In this study, we demonstrate that TMEM116 is highly expressed in non-small-cell lung cancer (NSCLC) tissues and cell lines. Inactivation of TMEM116 reduced cell proliferation, migration and invasiveness of human cancer cells and suppressed A549 induced tumor metastasis in mouse lungs. In addition, TMEM116 deficiency inhibited PDK1-AKT-FOXO3A signaling pathway, resulting in accumulation of TAp63, while activation of PDK1 largely reversed the TMEM116 deficiency induced defects in cancer cell motility, migration and invasive. Together, these results demonstrate that TMEM116 is a critical integrator of oncogenic signaling in cancer metastasis.
- 16 November 2021
- Published by Springer Nature in Cell Death & Disease
- Vol. 12 (12) , 1-11
Open AccessTMEM116 is required for lung cancer cell motility and metastasis through PDK1 signaling pathway
Transmembrane protein (TMEM) is a family of protein that spans cytoplasmic membranes and allows cell–cell and cell–environment communication. Dysregulation of TMEMs has been observed in multiple cancers. However, little is known about TMEM116 in cancer development. In this study, we demonstrate that TMEM116 is highly expressed in non-small-cell lung cancer (NSCLC) tissues and cell lines. Inactivation of TMEM116 reduced cell proliferation, migration and invasiveness of human cancer cells and suppressed A549 induced tumor metastasis in mouse lungs. In addition, TMEM116 deficiency inhibited PDK1-AKT-FOXO3A signaling pathway, resulting in accumulation of TAp63, while activation of PDK1 largely reversed the TMEM116 deficiency induced defects in cancer cell motility, migration and invasive. Together, these results demonstrate that TMEM116 is a critical integrator of oncogenic signaling in cancer metastasis.